NASDAQ · LABORATORY ANALYTICAL INSTRUMENTS · SMALL CAP
EyePoint, Inc. EYPT
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$31.4M
▼ 27.5% vs FY2024
EPS · FY25
$-3.17
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-72.2%
Net margin · FY25
-739.4%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 31.4M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 739 cents on every revenue dollar this year.
Per share
USD -3.17
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-72.2%
Return on equity, FY2025
ROE
Operating margin-776.0%
Net margin-739.4%
Return on assets-59.3%
Each USD of equity lost 72 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
−1.8% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−8.8%
−1.8%
+34.5%
+13.1%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.08B
Shares outstanding, FY2025
Change, 5 years+89.2%
Change, 10 years—
The share count grew 89% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 364.0M
total assets, end of FY2025
Total assetsUSD 364.0M
EquityUSD 306.1M
CashUSD 101.8M
Current ratio8.88×
Equity funds 84% of total assets.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.2
−0.1
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
0.0
EBITDA $B
−0.2
−0.1
−0.1
−0.1
−0.1
−0.0
−0.0
·
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
·
0.0
0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
0.0
Net income $B
−0.2
−0.1
−0.1
−0.1
−0.1
−0.0
−0.1
−0.1
−0.1
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
0.0
EPS, diluted $
−3.17
−2.32
−1.82
−2.74
−2.03
−3.54
−5.44
−1.27
−1.15
−0.52
−0.68
0.21
−0.49
−0.52
−1.19
−0.44
0.46
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−72.2
−43.4
−39.0
−72.8
−57.6
−337.9
−247.1
−349.2
−425.0
−108.0
−97.4
33.2
−118.1
−111.5
−97.3
−24.5
26.5
Shares out B
0.08
0.07
0.05
0.03
0.03
0.02
0.01
0.10
0.07
0.04
0.03
0.03
0.03
0.02
0.02
0.02
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
49 of 49
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed